Last reviewed · How we verify
Humoryl (TOLOXATONE)
At a glance
| Generic name | TOLOXATONE |
|---|---|
| Drug class | Monoamine Oxidase Inhibitors |
| Target | Amine oxidase [flavin-containing] A |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
| First approval | 1984 |
Approved indications
- Depressive disorder
Common side effects
Drug interactions
- Alpha/Beta Agonists
- Amphetamines
- Indirectly Acting Sympathomimetic Amines
- Selective Serotonin Reuptake Inhibitors
- Serotonin/Norepinephrine Reuptake Inhibitors
- Tricyclic Antidepressants
- buspirone
- dextromethorphan
- levodopa
- methyldopa
- mirtazapine
- pethidine
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Humoryl CI brief — competitive landscape report
- Humoryl updates RSS · CI watch RSS